tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH

Theravance Biopharma (TBPH) Revenue

Compare
310 Followers

Theravance Biopharma Revenue

Theravance Biopharma had a revenue of 15.39M in the quarter ending Mar 31, 2025, with -17.95%. This bring the company's revenue in the last twelve months to 65.27M, Decreased 1.37%. In the fiscal year ending Dec 31, 2024, Theravance Biopharma had annual revenue of 64.38M with 12.12% growth.
Revenue (ttm)
65.27M
Revenue Growth
6.11%
P/S Ratio
8.24
Revenue/Employee
$663,722
Employees
97
Market Cap
$530.51M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
64.38M6.96M+12.12%
Dec 31, 2023
57.42M6.08M+11.84%
Dec 31, 2022
51.35M-3.96M-7.17%
Dec 31, 2021
55.31M-16.55M-23.03%
Dec 31, 2020
71.86M-1.56M-2.12%
Dec 31, 2019
73.41M13.04M+21.61%
Dec 31, 2018
60.37M44.98M+292.37%
Dec 31, 2017
15.39M-33.26M-68.37%
Dec 31, 2016
48.65M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis